lung pain; myalgia; arthralgia; partially mentally absent, decreased concentration; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. regulatory number: at-basgages-2021-077953. a 82 year-old female patient received bnt162b2 (comirnaty), administration date 04nov2021 (batch/lot number: unknown) at the age of 82 years as dose 3 (booster), single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: comirnaty (dose 1, single.), for covid-19 immunisation; comirnaty (dose 2, single.), for covid-19 immunisation. the following information was reported: pulmonary pain (hospitalization) with onset 10dec2021, outcome "not recovered", described as "lung pain"; arthralgia (hospitalization) with onset 04nov2021, outcome "not recovered", described as "arthralgia"; myalgia (hospitalization) with onset 06dec2021, outcome "not recovered", described as "myalgia"; disturbance in attention (non-serious) with onset 10dec2021, outcome "not recovered", described as "partially mentally absent, decreased concentration". no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected